Full-Dose Azacitidine in 5 Days Versus 7 Days With a Weekend Break in Myelodysplastic Syndromes: A Retrospective Cohort Study

CONCLUSIONS: In higher-risk MDS, full-dose azacitidine (7 × 75 mg/m2) can be administered both in 5 days and in 7 days with a weekend break with no significant difference in survival, infection or transfusional outcomes.PMID:37867093 | DOI:10.1016/j.clml.2023.09.010
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research